Methanone, (4-chlorophenyl)[4-(8-nitro-5-quinolinyl)-1-piperazinyl]-, 97%, 250mg

N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2-nitrobenzene-1,4-diamine, 98%, 10g

2-Amino-6-bromo-4-fluorobenzothiazole, 95.0%, 1g

4-N-Butoxyphenylboronic acid, 95.0%, 100g

5-(4-Bromophenyl)pyrrolidin-2-one, 95.0%, 500mg

2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid, 95.0%, 5g

3-ETHOXY-4-NITROBENZOIC ACID, 95.0%, 1g

Proadifen hydrochloride, 95.0%, 100mg

2,6-BIS[(4S)-4,5-DIHYDRO-4-(1-METHYLETHYL)-5,5-DIPHENYL-2-OXAZOLYL]PYRIDINE, 95%, 50mg

1-Piperazinecarboxylic acid, 3-(aminocarbonyl)-, 1,1-dimethylethyl ester, (R)-, 95+%, 250mg

4-amino-1,2-butanediol, 95.0%, 250mg

3-(1H-Indol-3-yl)-4-(2-(4-methylpiperazin-1-yl)quinazolin-4-yl)-1H-pyrrole-2,5-dione, 98.0%, 250mg

Phthalic acid dimethyl ester, min. 99%, for synthesis, 2.5 l, glass packaging